Metabolism regulator adiponectin prevents cardiac remodeling and ventricular arrhythmias via sympathetic modulation in a myocardial infarction model
Basic Research in Cardiology · 2022-12 · 117 (1)
DOI: 10.1007/s00395-022-00939-2 ↗Kurz gefasst
Fachartikel in der Zeitschrift Basic Research in Cardiology, online erschienen am 11.07.2022. Verfasst von Zhen Zhou und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Renmin Hospital of Wuhan University, No. 238 Jiefang Road, Wuchang District, Wuhan, 430060, Hubei Province, People's Republ…. Hauptthemen laut MEDLINE: Adiponectin, Myocardial Infarction. Die Arbeit wurde bisher 51-mal zitiert (Crossref) und nennt 60 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Foundation for Innovative Research Groups of Hubei Province of China.
Abstract (Originalsprache)
The stellate ganglia play an important role in cardiac remodeling after myocardial infarction (MI). This study aimed to investigate whether adiponectin (APN), an adipokine mainly secreted by adipose tissue, could modulate the left stellate ganglion (LSG) and exert cardioprotective effects through the sympathetic nervous system (SNS) in a canine model of MI. APN microinjection and APN overexpression with recombinant adeno-associated virus vector in the LSG were performed in acute and chronic MI models, respectively. The results showed that acute APN microinjection decreased LSG function and neural activity, and suppressed ischemia-induced ventricular arrhythmia. Chronic MI led to a decrease in the effective refractory period and action potential duration at 90% and deterioration in echocardiography performance, all of which was blunted by APN overexpression. Moreover, APN gene transfer resulted in favorable heart rate variability alteration, and decreased cardiac SNS activity, serum noradrenaline and neuropeptide Y, which were augmented after MI. APN overexpression also decreased the expression of nerve growth factor and growth associated protein 43 in the LSG and peri-infarct myocardium, respectively. Furthermore, RNA sequencing of LSG indicated that 4-week MI up-regulated the mRNA levels of macrophage/microglia activation marker Iba1, chemokine ligands (CXCL10, CCL20), chemokine receptor CCR5 and pro-inflammatory cytokine IL6, and downregulated IL1RN and IL10 mRNA, which were reversed by APN overexpression. Our results reveal that APN inhibits cardiac sympathetic remodeling and mitigates cardiac remodeling after MI. APN-mediated gene therapy may provide a potential therapeutic strategy for the treatment of MI.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiology, Renmin Hospital of Wuhan University, No. 238 Jiefang Road, Wuchang District, Wuhan, 430060, Hubei Province, People's Republic of China.
- Cardiac Autonomic Nervous System Research Center of Wuhan University, Wuhan, 430060, People's Republic of China.
- Institute of Molecular Medicine, Renmin Hospital of Wuhan University, Wuhan, 430060, People's Republic of China.
- Cardiovascular Research Institute, Wuhan University, Wuhan, 430060, People's Republic of China.
- Hubei Key Laboratory of Cardiology, Wuhan, 430060, People's Republic of China.
- Department of Cardiology, Renmin Hospital of Wuhan University, No. 238 Jiefang Road, Wuchang District, Wuhan, 430060, Hubei Province, People's Republic of China. hong-jiang@whu.edu.cn.
Förderung
- National Natural Science Foundation of China
- Foundation for Innovative Research Groups of Hubei Province of China
Zitieren
APA
Zhou, Z., Liu, C., Xu, S., Wang, J., Guo, F., Duan, S., Deng, Q., Sun, J., Yu, F., Zhou, Y., Wang, M., Wang, Y., Zhou, L., Jiang, H., & Yu, L. (2022). Metabolism regulator adiponectin prevents cardiac remodeling and ventricular arrhythmias via sympathetic modulation in a myocardial infarction model. Basic Research in Cardiology, 117(1). https://doi.org/10.1007/s00395-022-00939-2
Vancouver
Zhou Z, Liu C, Xu S, Wang J, Guo F, Duan S, et al. Metabolism regulator adiponectin prevents cardiac remodeling and ventricular arrhythmias via sympathetic modulation in a myocardial infarction model. Basic Research in Cardiology. 2022;117(1). doi:10.1007/s00395-022-00939-2
BibTeX
@article{Zhou2022,
author = {Zhou, Zhen and Liu, Chengzhe and Xu, Saiting and Wang, Jun and Guo, Fuding and Duan, Shoupeng and Deng, Qiang and Sun, Ji and Yu, Fu and Zhou, Yuyang and Wang, Meng and Wang, Yueyi and Zhou, Liping and Jiang, Hong and Yu, Lilei},
title = {Metabolism regulator adiponectin prevents cardiac remodeling and ventricular arrhythmias via sympathetic modulation in a myocardial infarction model},
journal = {Basic Research in Cardiology},
year = {2022},
volume = {117},
number = {1},
doi = {10.1007/s00395-022-00939-2}
}
EUVIMED